Atlas Trials

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Clinical trial NCT04186819 · COMPLETED

Trial details

NCT number
NCT04186819
Sponsor
Blue Earth Diagnostics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2020-03-02
Primary completion
2021-06-21
Enrollment
356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.